Multiple primary tumors patient developed microsatellite stable gastric cancer after cadonilimab treatment for liver cancer: A case report

doi:10.5306/wjco.v16.i4.102418

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (101)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-1)

Sum=82

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=13

Apr 24, 2025 (publication date) through Mar 29, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Apr 24, 2025; 16(4): 102418
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.102418

Open in New Tab Full Size Figure Download Figure

Figure 1 Imaging changes of liver lesions after treatment. A: In April 2019; B: In May 2019; C: In January 2021; D: In October 2023.

Open in New Tab Full Size Figure Download Figure

Figure 2 Immunohistochemical results of gastric cancer in March 2024 (40 ×). A: Cytokeratin (+); B: CD20 (-); C: Cytokeratin 7 (+ in some cells); D: Ki-67 (about 60%).

Open in New Tab Full Size Figure Download Figure

Figure 3 Gastroscopic changes of gastric lesions after treatment. A: In October 2023; B: In December 2023; C: In March 2024.

Open in New Tab Full Size Figure Download Figure

Figure 4 Imaging changes of gastric lesions after treatment. A: In October 2023; B: In February 2024; C: In March 2024; D: In October 2023; E: In February 2024; F: In March 2024.

Open in New Tab Full Size Figure Download Figure

Figure 5 Treatment process. TACE: Transarterial chemoembolization; T + A: Atezolizumab + bevacizumab.

Citation: Luo SQ, Dai L, Zhou YJ, He T, Wang FJ, Jin XR, Wang Q. Multiple primary tumors patient developed microsatellite stable gastric cancer after cadonilimab treatment for liver cancer: A case report. World J Clin Oncol 2025; 16(4): 102418
URL: https://www.wjgnet.com/2218-4333/full/v16/i4/102418.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i4.102418